Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

40.04
Delayed Data
As of Dec 09
 +0.03 / +0.07%
Today’s Change
25.98
Today|||52-Week Range
40.75
+24.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues233.4M243.2M210.0M220.3M
 
 
 
 
 
Cost of Goods Sold101.8M131.8M95.3M93.3M
 
 
 
 
 
Depreciation And Amortization22.7M22.2M22.5M22.7M
 
 
 
 
 
 
Operating ExpensesGross Income108.9M89.2M92.2M104.2M
 
 
 
 
 
General Expenses86.2M82.3M82.6M77.9M
 
 
 
 
 
Research And Development10.9M11.7M11.4M8.3M
 
 
 
 
 
Total Operating Expenses210.8M236.3M200.4M193.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income22.6M6.8M9.6M26.4M
 
 
 
 
 
Extraordinary Credit5.1M0.00----
 
 
Extraordinary Charge-88.7M-12.4M-17.7M-2.0M
 
 
 
 
 
Interest Expense On Debt2.4M2.7M1.9M1.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-63.3M-8.3M-10.1M22.8M
 
 
 
 
 
Income Taxes-3.9M-467.0K-288.0K-3.0M
 
 
 
 
 
Net Income-59.4M-8.8M-10.3M19.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.7M50.9M51.0M51.4M
 
 
 
 
 
Shares To Calculate EPS Diluted50.7M50.9M51.0M51.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.17-$0.17-$0.20$0.38
 
 
 
 
 
EPS Diluted-$1.17-$0.17-$0.20$0.38